Efficacy and Safety Study of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines

NCT01776606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Aging

Interventions

DRUG: Botulinum Toxin Type A
DRUG: Placebo

Sponsor

Revance Therapeutics, Inc.